Cosmos Health (COSM) Non-Current Assets (2013 - 2026)
Cosmos Health's (COSM) quarterly Non-Current Assets came in at $24.8 million in Q2 2026, down 20.72% on a YoY basis from $31.3 million in Q2 2025, and down 2.69% quarter-over-quarter from $25.5 million in Q1 2026.
Analysis
Cosmos Health (COSM) Non-Current Assets (2013 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Non-Current Assets for 14 consecutive years, with $24.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 20.72% year-over-year to $24.8 million; the trailing twelve-month figure through Jun 2026 stood at $108.8 million (down 7.64% YoY), and the FY2025 full-year result was $27.1 million, down 6.1% from the prior year.
- Non-Current Assets eased to $24.8 million in Q2 2026 per COSM's latest filing, from $25.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $31.4 million in Q3 2025 and bottomed at $6.8 million in Q3 2022.
- Historically, Non-Current Assets has averaged $22.9 million across 5 years, with a median of $26.3 million in 2025.
- The sharpest annual moves came in 2023 and 2026: Non-Current Assets surged 269.73% in 2023, then fell 20.72% in 2026.
- Over 5 years, Non-Current Assets stood at $11.7 million in 2022, then jumped by 151.95% to $29.4 million in 2023, then retreated by 1.89% to $28.9 million in 2024, then declined by 6.1% to $27.1 million in 2025, then fell by 8.48% to $24.8 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $24.8 million, $25.5 million, and $27.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 26.10 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 24.99 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 2.92 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 1.83 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 18.27 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.04 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 668.68 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 1.11 Bn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 3.25 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 24.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.79 Mn |
| Mar 31, 2026 | 25.48 Mn |
| Dec 31, 2025 | 27.09 Mn |
| Sep 30, 2025 | 31.39 Mn |
| Jun 30, 2025 | 31.27 Mn |
| Mar 31, 2025 | 29.35 Mn |
| Dec 31, 2024 | 28.85 Mn |
| Sep 30, 2024 | 28.28 Mn |
| Jun 30, 2024 | 27.41 Mn |
| Mar 31, 2024 | 28.06 Mn |
| Dec 31, 2023 | 29.41 Mn |
| Sep 30, 2023 | 25.04 Mn |
| Jun 30, 2023 | 24.38 Mn |
| Mar 31, 2023 | 17.38 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 6.77 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 8.15 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 3.39 Mn |